This is a draft version - Page is not published

Financing, Equity Capital Markets

X4 Pharmaceuticals Inc.

12/22
|
$65.0 Million
X4
Piper Sandler served as left bookruuner for X4 Pharmaceuticals Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma